[Initial experiences with the use of gadolinium DTPA in infants and children under 2 years of age].
The use of Gadolinium-DTPA as a paramagnetic contrast agent in MRI with adults and juveniles concerning brain and spinal cord pathology is well proven since years. Tolerance and safety were excellent. In the FRG it is only introduced for children over two years of age. Therefore this report deals with the experience in four infants and small children under the age of two, who received gadolinium-DTPA for diagnostic purposes in pre- or post-operative circumstances. They all were suffering from neurological tumors and got additional diagnostic information in three cases. Clinical side-effects like urticaria, vomiting or convulsions had not been observed nor had pathologic changes of the biochemical parameters been noticed.
Maas
R
R
Abt. Röntgendiagnostik, Universitätsklinik Hamburg-Eppendorf.
Grzyska
U
U
Lausch
N
N
Bücheler
E
E
D016543:Central Nervous System Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D009942:Organometallic Compounds; D004369:Pentetic Acid
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; D019786:Gadolinium DTPA
Erste Erfahrungen beim Einsatz von Gadolinium-DTPA bei Säuglingen und Kleinkindern unter zwei Jahren.